These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 34126762

  • 41. Electrocardiographic (ECG) criteria for determining left ventricular mass in young healthy men; data from the LARGE Heart study.
    Sohaib SM, Payne JR, Shukla R, World M, Pennell DJ, Montgomery HE.
    J Cardiovasc Magn Reson; 2009 Jan 16; 11(1):2. PubMed ID: 19149884
    [Abstract] [Full Text] [Related]

  • 42. ECG left ventricular hypertrophy as a risk predictor of sudden cardiac death.
    Porthan K, Kenttä T, Niiranen TJ, Nieminen MS, Oikarinen L, Viitasalo M, Hernesniemi J, Jula AM, Salomaa V, Huikuri HV, Albert CM, Tikkanen JT.
    Int J Cardiol; 2019 Feb 01; 276():125-129. PubMed ID: 30293667
    [Abstract] [Full Text] [Related]

  • 43. Comparing the performance of artificial intelligence and conventional diagnosis criteria for detecting left ventricular hypertrophy using electrocardiography.
    Kwon JM, Jeon KH, Kim HM, Kim MJ, Lim SM, Kim KH, Song PS, Park J, Choi RK, Oh BH.
    Europace; 2020 Mar 01; 22(3):412-419. PubMed ID: 31800031
    [Abstract] [Full Text] [Related]

  • 44. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.
    Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Dahlof B, Losartan Intervention for Endpoint reduction in hypertension Study Investigations.
    Circulation; 2003 Aug 12; 108(6):684-90. PubMed ID: 12885747
    [Abstract] [Full Text] [Related]

  • 45. Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint.
    Okin PM, Wright JT, Nieminen MS, Jern S, Taylor AL, Phillips R, Papademetriou V, Clark LT, Ofili EO, Randall OS, Oikarinen L, Viitasalo M, Toivonen L, Julius S, Dahlöf B, Devereux RB.
    Am J Hypertens; 2002 Aug 12; 15(8):663-71. PubMed ID: 12160187
    [Abstract] [Full Text] [Related]

  • 46. The role of ECG in the diagnosis of left ventricular hypertrophy.
    Bacharova L, Schocken D, Estes EH, Strauss D.
    Curr Cardiol Rev; 2014 Aug 12; 10(3):257-61. PubMed ID: 24827796
    [Abstract] [Full Text] [Related]

  • 47. Signal averaged ECG in different patterns of left ventricular hypertrophy and geometry in hypertension.
    Wojszwiłło A, Łoboz-Grudzień K, Jaroch J.
    Kardiol Pol; 2003 May 12; 58(5):335-43. PubMed ID: 14523481
    [Abstract] [Full Text] [Related]

  • 48. Effect of changes in left ventricular anatomy and conduction velocity on the QRS voltage and morphology in left ventricular hypertrophy: a model study.
    Bacharova L, Szathmary V, Kovalcik M, Mateasik A.
    J Electrocardiol; 2010 May 12; 43(3):200-8. PubMed ID: 19709670
    [Abstract] [Full Text] [Related]

  • 49. Relating QRS voltages to left ventricular mass and body composition in elite endurance athletes.
    De Bosscher R, Moeyersons J, Dausin C, Claeys M, Janssens K, Claus P, Goetschalckx K, Bogaert J, Van De Heyning CM, Paelinck B, Sanders P, Kalman J, Van Huffel S, Varon C, La Gerche A, Heidbuchel H, Claessen G, Willems R, Pro@Heart consortium.
    Eur J Appl Physiol; 2023 Mar 12; 123(3):547-559. PubMed ID: 36376599
    [Abstract] [Full Text] [Related]

  • 50. Intravital and postmortem diagnostics of myocardial hypertrophy of the left ventricle:identity or convention?
    Bogomolov SN, Kulikov AN, Tikhonova JA, Solntsev VN, Rybakova MG, Gudkova AY, Kuchmin AN.
    Ter Arkh; 2018 Sep 20; 90(9):73-80. PubMed ID: 30701739
    [Abstract] [Full Text] [Related]

  • 51. Prognostic implications of left ventricular hypertrophy diagnosed on electrocardiogram vs echocardiography.
    Pedersen LR, Kristensen AMD, Petersen SS, Vaduganathan M, Bhatt DL, Juel J, Byrne C, Leósdóttir M, Olsen MH, Pareek M.
    J Clin Hypertens (Greenwich); 2020 Sep 20; 22(9):1647-1658. PubMed ID: 32813895
    [Abstract] [Full Text] [Related]

  • 52. Race- and sex-specific ECG models for left ventricular mass in older populations. Factors influencing overestimation of left ventricular hypertrophy prevalence by ECG criteria in African-Americans.
    Rautaharju PM, Park LP, Gottdiener JS, Siscovick D, Boineau R, Smith V, Powe NR.
    J Electrocardiol; 2000 Jul 20; 33(3):205-18. PubMed ID: 10954373
    [Abstract] [Full Text] [Related]

  • 53. Test characteristics of electrocardiography for detection of left ventricular hypertrophy in asymptomatic emergency department patients with hypertension.
    Mahn JJ, Dubey E, Brody A, Welch R, Zalenski R, Flack JM, Ference B, Levy PD.
    Acad Emerg Med; 2014 Sep 20; 21(9):996-1002. PubMed ID: 25269580
    [Abstract] [Full Text] [Related]

  • 54. Performance of electrocardiographic criteria for left ventricular hypertrophy as compared with cardiac computed tomography: from the Rule Out Myocardial Infarction Using Computer Assisted Tomography trial.
    Truong QA, Ptaszek LM, Charipar EM, Taylor C, Fontes JD, Kriegel M, Irlbeck T, Toepker M, Schlett CL, Bamberg F, Blankstein R, Brady TJ, Nagurney JT, Hoffmann U.
    J Hypertens; 2010 Sep 20; 28(9):1959-67. PubMed ID: 20498615
    [Abstract] [Full Text] [Related]

  • 55. Automatic learning of rules. A practical example of using artificial intelligence to improve computer-based detection of myocardial infarction and left ventricular hypertrophy in the 12-lead ECG.
    Kaiser W, Faber TS, Findeis M.
    J Electrocardiol; 1996 Sep 20; 29 Suppl():17-20. PubMed ID: 9238372
    [Abstract] [Full Text] [Related]

  • 56. Impact of electrocardiographic findings for diagnosis of left ventricular hypertrophy in patients with primary aldosteronism.
    Kurisu S, Iwasaki T, Mitsuba N, Ishibashi K, Dohi Y, Kihara Y.
    J Renin Angiotensin Aldosterone Syst; 2015 Mar 20; 16(1):131-6. PubMed ID: 23535447
    [Abstract] [Full Text] [Related]

  • 57. Utility of electrocardiogram for predicting increased left ventricular mass in asymptomatic men at risk for cardiovascular disease.
    Denarié N, Linhart A, Levenson J, Simon A.
    Am J Hypertens; 1998 Jul 20; 11(7):861-5. PubMed ID: 9683049
    [Abstract] [Full Text] [Related]

  • 58. Relation of echocardiographic left ventricular mass and hypertrophy to persistent electrocardiographic left ventricular hypertrophy in hypertensive patients: the LIFE Study.
    Okin PM, Devereux RB, Jern S, Julius S, Kjeldsen SE, Dahlöf B.
    Am J Hypertens; 2001 Aug 20; 14(8 Pt 1):775-82. PubMed ID: 11497193
    [Abstract] [Full Text] [Related]

  • 59. R Wave in aVL Lead is a Robust Index of Left Ventricular Hypertrophy: A Cardiac MRI Study.
    Courand PY, Grandjean A, Charles P, Paget V, Khettab F, Bricca G, Boussel L, Lantelme P, Harbaoui B.
    Am J Hypertens; 2015 Aug 20; 28(8):1038-48. PubMed ID: 25588700
    [Abstract] [Full Text] [Related]

  • 60. ECG identification of left ventricular hypertrophy. Relationship of test performance to body habitus.
    Okin PM, Roman MJ, Devereux RB, Kligfield P.
    J Electrocardiol; 1996 Aug 20; 29 Suppl():256-61. PubMed ID: 9238409
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.